In the US, Aldesleukin (aldesleukin systemic) is a member of the following drug classes: interleukins, miscellaneous antineoplastics and is used to treat Melanoma, Melanoma - Metastatic and Renal Cell Carcinoma.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Biological response modifier, BRM
125-L-serine-2-133-interleukin 2 (human reduced) (WHO)
2-133-Interleukin 2 (human reduced), 125-L-serine- (USAN)
Des-alanyl-1, serine-125 human interleukin-2 (BAN)
- Aldesleukinum (Latin)
- Aldesleukin (German)
- Aldesleukine (French)
- Aldesleukina (Spanish)
- Aldesleukin (OS: BAN, USAN)
- Aldesleukine (OS: DCF)
- IL-2 (IS)
- Interleukin-2 human (IS: 1-des-Ala, 125 Ser)
- recombinant human interleukin-2 (IS)
- r-serHulL-2 (IS)
Chiron, Egypt; Novartis, Belgium; Novartis, Czech Republic; Novartis, Denmark; Novartis, Finland; Novartis, France; Novartis, Greece; Novartis, Hungary; Novartis, Iceland; Novartis, Lithuania; Novartis, Netherlands; Novartis, Portugal; Novartis, Turkey; Novartis, Taiwan; Novartis Consumer Health, United States; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis Pharma, Austria; Novartis Pharma, Switzerland; Novartis Pharma, Israel; Novartis Pharma, Lebanon; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom; Prometheus, United States; Tecnofarma, Ecuador; Zodiac, Brazil
- Proleukin Hyupjin
Hyup Jin, South Korea
- Proleukin S
Novartis Pharma, Germany
- Xin Mei Ge
CP Guojian Pharmaceutical, China
|BAN||British Approved Name|
|DCF||Dénomination Commune Française|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.